Today: 26 April 2026
Medical Properties Trust stock holds near $6 after earnings pop — here’s what matters before the open
20 February 2026
2 mins read

Medical Properties Trust stock holds near $6 after earnings pop — here’s what matters before the open

New York, Feb 20, 2026, 09:20 EST — Premarket

  • MPT edged up about 0.1% premarket, after jumping 12.1% the previous session.
  • Hospital REIT posted fourth-quarter earnings and revealed a new California lease deal tied to the former Prospect hospitals.
  • Rent ramp timing is front and center for investors, with refinancing risk in 2026 also high on their radar.

Medical Properties Trust was mostly unchanged in premarket trading Friday, ticking up about 0.1% and hovering near $6.03. Thursday saw the stock surge 12.1%, pushing it to a 52-week high of $6.47.

The move stands out, coming after a year focused on securing rent, with tenants under pressure, leases reworked, assets offloaded. Still, when it comes to this stock, a sharp rally can disappear fast if questions remain about the true stability of cash flow.

This lands just ahead of the new session—REITs could swing hard if rate expectations shift. With MPT, it’s down to execution: Will management actually pull off promised rent hikes and the balance sheet repair, on the timeline they’ve set?

The company reported fourth-quarter net income of $0.03 per share Thursday and unveiled a new 15-year lease covering six California hospitals formerly operated by Prospect Medical Holdings. Annual cash rent is expected to hit $45 million by December 2026. CEO Edward Aldag said Prospect’s bankruptcy process is “largely behind us.” SEC

Revenue landed at about $270.3 million for the quarter, rising from $231.8 million in the same period last year. Normalized funds from operations, the $0.18 per share figure—REIT investors’ go-to gauge for stripping out certain one-time items—held steady.

MPT has overhauled its arrangement with Vibra Healthcare, securing a new 20-year master lease and pulling in a one-time rent payment of $18 million. The company also shelled out about $32 million for a U.S. post-acute facility in the quarter. In February, it picked up an additional European property for roughly €23 million. MPT also repurchased close to 4.5 million shares, spending $23.4 million.

Aldag, on the call, highlighted that total portfolio EBITDARM coverage has climbed year over year to 2.6x, signaling more headroom for tenants meeting rent. CFO R. Steven Hamner called out the €500 million notes set to mature in October, describing them as the company’s “nearest maturity.” Kevin Hanna put normalized FFO “about $0.03 to $0.04 higher,” attributing that lift to a one-off influx of cash. Insider Monkey

The Prospect story continued to dominate. MPT said it’s almost wrapped up its dealings tied to Prospect’s court-led restructuring, a process that started in January 2025. Back in January, MPT unloaded two Connecticut hospitals; one more property remains under a binding agreement, with closing anticipated sometime in the first quarter.

Debt remains a heavy drag. Medical Properties Trust’s latest quarterly supplement put net debt near $9.7 billion as of year-end. That figure covers roughly $638 million drawn on a secured credit facility, with another €500 million in notes set to mature in 2026. The company says it’s issued a notice to extend the credit facility’s maturity to June 30, 2027, if certain conditions are met.

Downside risk isn’t off the table. The whole story comes down to rent checks arriving on time, asset sales getting done, and capital markets staying open for refinancing or extending those 2026 maturities. Should any of those pieces slip, tougher decisions on leverage and distributions could be in the cards for the company.

Traders are watching to see if the stock keeps its post-earnings jump as the day gets underway. There’s focus on a few things: the expected sale of the final Connecticut facility in the first quarter, partial rent scheduled to begin at the California hospitals in June, plus how MPT plans to handle the euro notes coming due in October.

Stock Market Today

  • BP Shareholder Revolt Highlights Governance and Climate Disclosure Concerns
    April 26, 2026, 5:31 AM EDT. At BP's 2026 AGM, nearly 20% of shareholders opposed chairman Albert Manifold's re-election and rejected board-backed resolutions on climate disclosure and governance. Proposals to reduce climate reporting and move AGMs fully online were defeated, signaling investor insistence on stricter oversight. Despite BP's shares rising 30.6% year-to-date, the shareholder pushback underscores tensions over the company's energy transition strategy and governance approach. Major investors, including Legal & General Investment Management and proxy adviser Glass Lewis, voiced concerns on climate policy and board accountability. The revolt emphasizes that governance and climate risks remain central to how institutions evaluate BP amid its upstream-heavy portfolio. The coming months may see intensified engagement between the board and shareholders as climate targets and disclosures stay under scrutiny.

Latest article

Wall Street Feels the Heat (and Thrill): Fed Cuts, Tariffs & Mega-Mergers Set NYSE Buzz

US Stock Market Today: Live Updates 26.04.2026

26 April 2026
LIVEMarkets rolling coverageStarted: April 26, 2026, 12:00 AM EDTUpdated: April 26, 2026, 5:32 AM EDT Predictive Discovery Completes Robex Merger, Resets Gold Valuation Story April 26, 2026, 5:32 AM EDT. Predictive Discovery Limited (ASX:PDI) has finalised its merger with Robex Resources, uniting their West African gold assets under one group. The company plans an investor webinar to outline updated production targets and capital allocation strategies. This move reshapes PDI's profile amid a gold sector influenced by inflation, currency shifts, and geopolitical risk. Shares currently trade around A$0.955, roughly 38% below analyst target midpoint of A$1.55, but recent 30-day gains near
Lockheed Martin Gets Golden Dome Opening as Profit Worries Bite

Lockheed Martin Gets Golden Dome Opening as Profit Worries Bite

26 April 2026
Lockheed Martin was named among firms awarded up to $3.2 billion for President Trump’s Golden Dome space-based missile interceptor plan, Space Systems Command said. The company reported weaker first-quarter results, with $18 billion in sales and negative free cash flow. Space Force aims to show initial interceptor capability in 2028. Golden Dome’s total cost is projected at $185 billion.
Neptune Insurance (NP) stock jumps on upgrades — here’s what to watch at today’s open
Previous Story

Neptune Insurance (NP) stock jumps on upgrades — here’s what to watch at today’s open

OXY stock price wobbles after earnings jump as debt move and dividend hike come into view
Next Story

OXY stock price wobbles after earnings jump as debt move and dividend hike come into view

Go toTop